| Tag | Content |
|---|
EnhancerAtlas ID | HS016-00238 |
Organism | Homo sapiens |
Tissue/cell | CD14+ |
Coordinate | chr13:49226950-49228980 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr13:49228044-49228065 | TTGCTCTTTCACTTTTCTTTG | + | 6.38 | | RFX1 | MA0509.2 | chr13:49227750-49227766 | TGTTGCCATGGAAACA | + | 6.89 | | RFX1 | MA0509.2 | chr13:49227750-49227766 | TGTTGCCATGGAAACA | - | 6.91 | | RFX2 | MA0600.2 | chr13:49227750-49227766 | TGTTGCCATGGAAACA | - | 7.11 | | RFX2 | MA0600.2 | chr13:49227750-49227766 | TGTTGCCATGGAAACA | + | 7.17 | | RFX5 | MA0510.2 | chr13:49227750-49227766 | TGTTGCCATGGAAACA | - | 7.05 | | RFX5 | MA0510.2 | chr13:49227750-49227766 | TGTTGCCATGGAAACA | + | 7.06 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_49855 | chr13:49226039-49228193 | RPMI-8402 | | SE_49855 | chr13:49228425-49231701 | RPMI-8402 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr13 | 49227582 | 49227800 | | chr13 | 49227800 | 49228200 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH13I048652 | chr13 | 49226944 | 49229736 |
|
Enhancer Sequence | TATCTTCAGG TTTTTCTACA TATAAGATTT TATCATTTGC AAACAGACAA AATTTTACTT 60
ATTTATTTCC AATTTGGATC CCTTTTACTT ATTTTTCTTG CTTAATGTTA CTGCAGCTTT 120
CTATGCAGGA AACGAGGATT TGAACAGTGA TGGAGAGATG AGTAATGGTT CGATTTGGAA 180
CATATTTTAT GGGCAGAACA AATGGAACTT GTTGGCTCAG AAGTGGGTGG TGGAAGAAAG 240
AGGGAAGTTA AAAGTGACTT CTAGGTTTAT GGATGGATGA ACTGGCTAAA TTATTGTGGT 300
GCCATTTGCT TAGACAGGGT AGATGGGGGG ATGCAGGACT AAGAGAGGAA GAGAAAAGCT 360
CCACCTGGGC CACATTAAAT TTGGCCATGA TTGTGGATCA GATAGGTAAA AGCAAGAGAA 420
GGAGGGAAGA AGTCAGAACA CAGACCTCTG GGGAAAGCTC ACACGTAGAA AAGGGGTGGA 480
AGAAGAGGCA TCAGAAAGAG AGGCAAAGAA GAGCAATCTG AGGGGTAGAA AAAGAACCAG 540
GAAAGTCAGA GAAAAAAGGG AAAAGTTTCA GGAAAGTGGC AATGGTCAAC TATGCAAACA 600
AGAGGGGAAG GAAGGTGAGG ACTGAGAAAG GATTTTTTAT GTAAGCAACA AGGAGGTTTT 660
TGGTGACCTC TGACAGAACA TTTTCAGCAG ACTGGATAAG GTCTCTGCCT GAGTGCAAGT 720
GAGCTGAAAA TGCAAGTGAG TGAGGGAAGT GCTTTAAAAA AGTCTAAAGT GCTATGTGTG 780
TAAGGCAATG TTGCTATTTC TGTTGCCATG GAAACAGAAA CCATTTAGGA GAACTAAAAG 840
CCACTTAAAA TTCCTGACTC TAACCCATCA TATCCGCTTG ATCTCTTGAG AAAGATAATG 900
ACAAAAAACC AGTCATTAGA GGGGCAGGGC AATTTTAGGT TTCTTCTTTT TAGACATAGC 960
CCCTAACTGG AAATTTTCAC CCTTCTTGAG AAGGGAGCTT GCACTAACAT CTACAATGGC 1020
TTCTAAAAAG CACAGATGAC CTGCTACACT TCCTGACTTG CTTGCTATTG GTTGGCACTG 1080
TTCATAAATA TAATTTGCTC TTTCACTTTT CTTTGAAATG AGCAACCTGA ATTACTCGGA 1140
GGAGAAAGGC AGGAGAGATA GAGGCAGCAG AAGCCAGGGC AGCTGAAAGA CAGAGACCTT 1200
CAGGTGGGCA TTTTAATCTT TGTTTTGTTA ATTCAGTGTT GAGCATCATG ACTTGATGAT 1260
CACATAATAG TCAGAGGAGT AATTTTTTAA AAGTAAATTT GTTTTGTTCT ACTATAAATG 1320
TTATTTTCCT ATCATGTACA TGGTAGTTTA AAAAATACTG TGGAAGTATA AAAATGTTGA 1380
AAGAAGCCAA ATTCTCCACC AAAATAGCCT CTATTGATAT TTTGGGGATC GTCCCTTTGT 1440
GTGTGTGTGT GTGTGTGTGT GTGTGTGTGT GTGTGTGTGT GTGTGTGTGT GAGTGTGTGT 1500
GTGTGTGTGT GTATGCACAT ATAACTTTAG TTTTCATAGT TGCGTCCCTA CACTATGGAC 1560
AAGTTTGTAT TCATTTCCTC CATATCAGTC TATGGTTTTT CCATGTTGCT GTGAATTCTT 1620
TGTAATCATA AATTAAAGCT GCTGCATATT ATTGCATTGA GGAACTTTAC TATACTTCCT 1680
CCATTTTTGG CTGTTATCCT CTTTTTCATA GTTTGGGTCC TTCTATTATA TAAGATATAT 1740
TTTTTCCATT CAGTGTCTTG TTTTAGGGGT AGAAGAAGTT AAATCTGAGC ACATATATTT 1800
CAATGGTTTT GCTCAGAGGC ACAATGAGAA TGAAAGAGTA TGTGAGATCA TGAGCATATA 1860
ATCTGTTCCT TACCCCACTG GGACCCTAAT CAGTGTTTCT CAACCCTGGC TGCACATCTG 1920
GCCAGAATCA CCCGACTCTG AGGAGATTAG AAAATTACCC CTAGAATAAC TGAAGCTTAA 1980
CTTTTGGAGA TCAGTGAGTC ATCTGCAGTA TTTTATCTTG TTTTCCAGAA 2030
|
